August 26--PRNewswire/AsiaNet
YOKOHAMA: A new international study shows Risperdal Consta, a long acting injection for the treatment of schizophrenia, can reduce the need for hospitalisation amongst sufferers, reports Janssen-Cilag. Pierre Chue, a professor of psychiatry at the University of Alberta said "A treatment that can help keep more of these individuals out of the hospital and functioning independently is a significant benefit not only for them, but for society at large."
BEIJING: CNOOC said they have received an offer to acquire Australian Gas Reserves. The company reported they will outlay US$320 million to purchase an approximate 5% interest in the upstream reserves of Australia's North West Shelf Gas Project.
SAN FRANCISCO: An alliance between YesAsia.com and Kingstone, the largest bookstore chain in Taiwan will be used to promote Chinese books to overseas Chinese communities, a media release said. "Partners can easily upload products to YesAsia.com, effectively reaching the company's 150,000 customers, and sell their books via this new channel," said Albert Wong, YesAsia.com's IT and Operation Director.
HONG KONG: Crude oil producer, CNOOC today announced a net profit of RMB 3.62 billion for the first half of 2002. Mr. Wei Liucheng, the Company's Chairman and CEO said "we are extremely pleased with the progress the company has made in executing its strategy, delivering on its promises, and creating shareholder value."
ZURICH: Medical device specialist, Centerpulse reported net income was up 118% during the first six months of 2002. CEO, Max Link said "during the second half of the year we intend to achieve greater improvements in profitability and in operating results."
SAN DIEGO: Financial guidance for the full year 2002 and for 2003 was today announced by Gen-Probe Incorporated, developer of nucleic acid testing products. The company said they expect total fiscal year 2002 revenues of approximately $145 million.
ZURICH: The Board of Directors at Centerpulse has named Johannes Randegger as Lead Director, the company reported today. A media release said the primary function of Lead Director was to help avoid any interest conflicts that may result through the dual functions of the company's Chairman and CEO, Max Link.
ZURICH: Mike McCormick was appointed President of the Spine-Tech Division at Centerpulse, the company announced today. A media release said the previous manager of Spine-Tech, Dennis Wallach, will specialise in the sale of Centerpulse's Cardiac and Vascular Divisions.
(AsiaNet is a consortium of leading news agencies distributing unedited,translated press releases for worldwide clients. Contact: www.asianetnews.net for full-text versions).
ติดต่อเราได้ที่ facebook.com/newswit